Kendra Roloff, NP
Nurse Practitioner · Bismarck
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 18 years
- Graduated 2008
Offices
2 locations · Bradley Gynecology PC · Omaha Therapy Inc
Hospitals listed: Chi St Alexius Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kendra Roloff’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Chi St Alexius HealthBismarck, NDAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 789 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Chi St Alexius Health
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 789 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.16 (0.15 to 2.18) · 693 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.17 (0.83 to 1.51) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 168.12 (113.27 to 222.96) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.8 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 231 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 158 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 141 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,625 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.02 to 0.45) · 3,156 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.11 to 0.52) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.17 (0.96 to 5.38) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 344 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 825 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.26 (9.28 to 21.24) · 336 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.32 (3.66 to 10.99) · 312 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.31) · 2,819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6 · 49 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.6 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.61 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.867 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 165 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 289 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 4.6 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.5 · 249 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 19.2 · 165 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 187 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.1) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.4 to 14.8) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 318 cases | No different | Jan 2022 – Dec 2024 |
What patients said (596 patients answered, 28% of those asked)
| Cleanliness | 1 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 57% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$36,102
Medicare paid this office $36,102 for 176 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 37 | $8,031 | $217 |
| Insertion of device into abdomen with pressure and urine flow rate study | 37 | $4,605 | $124 |
| Short return visit (20+ min) | 55 | $4,031 | $51 |
| Insertion of lower leg neurostimulator electrode | 13 | $3,674 | $61 |
| New patient visit (45+ min) | 38 | $3,505 | $92 |
See all 14 services
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 37 | $8,031 | $217 |
| Insertion of device into abdomen with pressure and urine flow rate study | 37 | $4,605 | $124 |
| Short return visit (20+ min) | 55 | $4,031 | $51 |
| Insertion of lower leg neurostimulator electrode | 13 | $3,674 | $61 |
| New patient visit (45+ min) | 38 | $3,505 | $92 |
| Short return visit | 45 | $2,046 | $30 |
| Return visit (30+ min) | 23 | $2,014 | $81 |
| Pessary, reusable, non rubber, any type | 15 | $1,064 | $53 |
| Fitting and insertion of vaginal support device | 16 | $1,046 | $45 |
| New patient visit (30+ min) | 14 | $940 | $67 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 37 | $774 | $21 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 18 | $700 | $32 |
| Ultrasound measurement of bladder capacity after voiding | 47 | $410 | $8 |
| Electronic assessment of bladder emptying | 60 | $400 | $6 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of lower leg neurostimulator electrode | 213 | 184 | 117 | 147 | 277 | 60 |
| Electronic assessment of bladder emptying | 65 | 64 | 99 | 98 | 86 | 64 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 73 | 70 | 67 | 46 | 39 | 37 |
| Insertion of device into abdomen with pressure and urine flow rate study | 51 | 42 | 45 | 45 | 40 | 37 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 49 | 41 | 44 | 44 | 39 | 37 |
| Ultrasound measurement of bladder capacity after voiding | 20 | 16 | 29 | 33 | 35 | 52 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
176 Original Medicare patients in 2024. Average age 75 · Also on Medicaid 14% · Health risk score 1.06. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 73% · Depression 34% · Diabetes 32% · Chronic kidney disease 23% · Coronary heart disease 20% · Heart failure 18% · Cancer 14% · COPD 12% · Atrial fibrillation 12% · Stroke 8%.
The office billed $134,135, Medicare allowed $50,987 and paid $36,102; for 624 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 176 | 624 | 75 | 1.06 | $134,135 | $36,102 |
| 2023 | 203 | 898 | 75 | 1.05 | $201,955 | $58,470 |
| 2022 | 199 | 784 | 75 | 1.06 | $168,559 | $49,672 |
| 2021 | 203 | 755 | 75 | 1.09 | $164,765 | $48,548 |
| 2020 | 202 | 720 | 74 | 0.98 | $175,563 | $48,769 |
| 2019 | 194 | 785 | 75 | 1.10 | $205,937 | $52,063 |
| 2018 | 157 | 800 | 75 | 1.11 | $175,240 | $44,705 |
| 2017 | 150 | 823 | 74 | 1.17 | $177,415 | $45,678 |
| 2016 | 113 | 544 | 72 | 1.01 | $120,830 | $34,076 |
| 2015 | 81 | 339 | 72 | 0.95 | $51,773 | $14,175 |
| 2014 | 102 | 513 | 72 | 0.80 | $94,275 | $25,745 |
| 2013 | 34 | 149 | 74 | 0.88 | $44,675 | $7,144 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Insertion of lower leg neurostimulator electrode | 28 | $20,690 | $75 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 38 | $9,445 | $242 |
| Insertion of device into abdomen with pressure and urine flow rate study | 39 | $5,054 | $126 |
| Short return visit (20+ min) | 54 | $3,797 | $51 |
| New patient visit (45+ min) | 35 | $3,542 | $101 |
| New patient visit (60+ min) | 28 | $3,444 | $123 |
| Short return visit | 61 | $3,201 | $35 |
| New patient visit (30+ min) | 36 | $2,499 | $69 |
| Return visit (30+ min) | 18 | $1,265 | $67 |
| Pessary, reusable, non rubber, any type | 15 | $1,127 | $54 |
| Fitting and insertion of vaginal support device | 14 | $960 | $48 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 38 | $802 | $21 |
| Irrigation of vagina and/or application of drug to treat infection | 14 | $791 | $33 |
| Electronic assessment of bladder emptying | 78 | $548 | $6 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 13 | $505 | $32 |
| Ultrasound measurement of bladder capacity after voiding | 28 | $259 | $7 |
2022: 14 services
| Insertion of lower leg neurostimulator electrode | 25 | $11,932 | $81 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 43 | $10,166 | $231 |
| Insertion of device into abdomen with pressure and urine flow rate study | 44 | $6,155 | $137 |
| New patient visit (45+ min) | 58 | $5,443 | $94 |
| Short return visit | 90 | $4,685 | $32 |
| Short return visit (20+ min) | 40 | $2,674 | $59 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 45 | $1,012 | $22 |
| New patient visit (30+ min) | 14 | $987 | $70 |
| Pessary, reusable, non rubber, any type | 12 | $822 | $48 |
| Fitting and insertion of vaginal support device | 12 | $775 | $46 |
| Insertion of temporary bladder tube | 18 | $742 | $29 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 15 | $703 | $35 |
| Electronic assessment of bladder emptying | 92 | $611 | $6 |
| Ultrasound measurement of bladder capacity after voiding | 30 | $273 | $8 |
2021: 14 services
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 44 | $11,510 | $262 |
| Insertion of lower leg neurostimulator electrode | 18 | $9,902 | $85 |
| Insertion of device into abdomen with pressure and urine flow rate study | 45 | $5,858 | $130 |
| Short return visit | 92 | $5,133 | $36 |
| New patient visit (45+ min) | 48 | $4,778 | $100 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 66 | $1,861 | $28 |
| New patient visit (30+ min) | 23 | $1,657 | $72 |
| Short return visit (20+ min) | 25 | $1,325 | $47 |
| Pessary, reusable, non rubber, any type | 12 | $1,149 | $48 |
| Fitting and insertion of vaginal support device | 12 | $1,076 | $45 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 16 | $683 | $34 |
| Electronic assessment of bladder emptying | 88 | $681 | $7 |
| Insertion of temporary bladder tube | 12 | $310 | $26 |
| Ultrasound measurement of bladder capacity after voiding | 26 | $206 | $7 |
2020: 12 services
| Insertion of lower leg neurostimulator electrode | 40 | $15,078 | $82 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 41 | $9,836 | $240 |
| Short return visit (20+ min) | 81 | $5,367 | $44 |
| New patient visit (45+ min) | 56 | $5,339 | $95 |
| Insertion of device into abdomen with pressure and urine flow rate study | 42 | $4,680 | $111 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 65 | $2,127 | $30 |
| Pessary, reusable, non rubber, any type | 12 | $713 | $45 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 12 | $655 | $39 |
| Irrigation of vagina and/or application of drug to treat infection | 13 | $622 | $37 |
| Fitting and insertion of vaginal support device | 11 | $532 | $41 |
| Electronic assessment of bladder emptying | 63 | $405 | $6 |
| Ultrasound measurement of bladder capacity after voiding | 15 | $132 | $8 |
2019: 13 services
| Insertion of lower leg neurostimulator electrode | 49 | $17,980 | $84 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 49 | $10,608 | $216 |
| Short return visit (20+ min) | 74 | $5,170 | $44 |
| Insertion of device into abdomen with pressure and urine flow rate study | 51 | $4,807 | $94 |
| New patient visit (45+ min) | 37 | $3,774 | $102 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 70 | $2,169 | $30 |
| Return visit (30+ min) | 34 | $2,162 | $62 |
| Insertion of temporary bladder tube | 30 | $810 | $27 |
| Fitting and insertion of vaginal support device | 14 | $774 | $32 |
| Pessary, reusable, non rubber, any type | 12 | $641 | $46 |
| Electronic assessment of bladder emptying | 63 | $381 | $6 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $260 | $15 |
| Ultrasound measurement of bladder capacity after voiding | 18 | $141 | $7 |
2018: 13 services
| Insertion of lower leg neurostimulator electrode | 33 | $13,419 | $84 |
| Short return visit (20+ min) | 75 | $5,942 | $45 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 26 | $5,709 | $220 |
| Return visit (30+ min) | 47 | $3,327 | $64 |
| Long return visit (40+ min) | 29 | $2,352 | $81 |
| Insertion of device into abdomen with pressure and urine flow rate study | 27 | $2,078 | $77 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 45 | $1,869 | $34 |
| Fitting and insertion of vaginal support device | 13 | $1,630 | $44 |
| Insertion of temporary bladder tube | 43 | $1,317 | $31 |
| Ultrasound measurement of bladder capacity after voiding | 28 | $418 | $11 |
| Electronic assessment of bladder emptying | 47 | $399 | $7 |
| Irrigation of vagina and/or application of drug to treat infection | 12 | $377 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $276 | $15 |
2017: 15 services
| Insertion of lower leg neurostimulator electrode | 33 | $14,394 | $85 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 33 | $7,232 | $219 |
| Short return visit (20+ min) | 61 | $4,646 | $47 |
| Return visit (30+ min) | 61 | $4,010 | $66 |
| Study of rectum sensitivity and function | 12 | $2,961 | $148 |
| Insertion of device into abdomen with pressure and urine flow rate study | 33 | $2,446 | $74 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 44 | $1,588 | $31 |
| Fitting and insertion of vaginal support device | 13 | $1,195 | $48 |
| Insertion of temporary bladder tube | 28 | $939 | $30 |
| Test or measurement for functional capacity, each 15 minutes | 12 | $903 | $22 |
| Electronic assessment of bladder emptying | 67 | $593 | $8 |
| Ultrasound measurement of bladder capacity after voiding | 21 | $411 | $14 |
| Application of electrical stimulation with therapist present, each 15 minutes | 12 | $388 | $9 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $352 | $14 |
| Irrigation of vagina and/or application of drug to treat infection | 11 | $255 | $18 |
2016: 8 services
| Insertion of lower leg neurostimulator electrode | 26 | $15,412 | $85 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 25 | $4,190 | $168 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 33 | $3,553 | $79 |
| Short return visit (20+ min) | 37 | $2,390 | $44 |
| Return visit (30+ min) | 25 | $1,635 | $63 |
| Insertion of device into abdomen with pressure and urine flow rate study | 25 | $1,382 | $55 |
| Fitting and insertion of vaginal support device | 11 | $804 | $45 |
| Electronic assessment of bladder emptying | 51 | $321 | $6 |
2015: 12 services
| Insertion of lower leg neurostimulator electrode | 19 | $4,065 | $73 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 14 | $2,344 | $167 |
| Return visit (30+ min) | 27 | $1,872 | $67 |
| Short return visit (20+ min) | 27 | $1,557 | $40 |
| Insertion of device into abdomen with pressure and urine flow rate study | 13 | $736 | $57 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | $634 | $45 |
| Detection test for candida species (yeast), direct probe technique | 12 | $321 | $27 |
| Detection test for gardnerella vaginalis (bacteria), direct probe technique | 12 | $321 | $27 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique | 12 | $321 | $27 |
| Electronic assessment of bladder emptying | 31 | $241 | $7 |
| Bacterial colony count, urine | 15 | $194 | $11 |
| Manual urinalysis test with examination using microscope, automated | 24 | $114 | $4 |
2014: 10 services
| Insertion of lower leg neurostimulator electrode | 26 | $11,598 | $78 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 25 | $4,020 | $161 |
| Short return visit (20+ min) | 45 | $2,324 | $44 |
| Insertion of device into abdomen with pressure and urine flow rate study | 25 | $1,350 | $54 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 25 | $1,086 | $43 |
| Return visit (30+ min) | 15 | $1,061 | $71 |
| Short return visit | 28 | $774 | $26 |
| Electronic assessment of bladder emptying | 50 | $300 | $6 |
| Bacterial colony count, urine | 11 | $140 | $11 |
| Manual urinalysis test with examination using microscope, automated | 13 | $68 | $4 |
2013: 2 services
| Short return visit (20+ min) | 11 | $716 | $48 |
| Electronic assessment of bladder emptying | 12 | $73 | $6 |
Drugs they prescribed that Part D paid
$131,613
Pharmacies billed $131,613 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 557) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
358 generic and 199 brand-name prescriptions · $131,613 in drug cost · 32 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 131 | $65,860 | $503 |
| Myrbetriq | 40 | $21,317 | $533 |
| Estradiol | 136 | $15,578 | $115 |
| Estring | 19 | $10,253 | $540 |
| Fesoterodine Fumarate Er | 48 | $5,768 | $120 |
See all 10 drugs
| Gemtesa | 131 | $65,860 | $503 |
| Myrbetriq | 40 | $21,317 | $533 |
| Estradiol | 136 | $15,578 | $115 |
| Estring | 19 | $10,253 | $540 |
| Fesoterodine Fumarate Er | 48 | $5,768 | $120 |
| Solifenacin | 77 | $2,114 | $27 |
| Methenamine Hippurate | 19 | $1,425 | $75 |
| Trospium Chloride | 13 | $993 | $76 |
| Tolterodine Tartrate Er | 11 | $927 | $84 |
| Nitrofurantoin Mono-Macro | 19 | $169 | $9 |
Year by year
| 2024 | 557 | 167 | 0% (0) | 36% | $131,613 |
| 2023 | 375 | 105 | 0% (0) | 30% | $73,891 |
| 2022 | 437 | 102 | 0% (0) | 26% | $70,843 |
| 2021 | 386 | 97 | 0% (0) | 49% | $73,017 |
| 2020 | 328 | 84 | 0% (0) | 56% | $65,739 |
| 2019 | 261 | 73 | 0% (0) | 69% | $63,477 |
| 2018 | 194 | 58 | 0% (0) | 73% | $60,429 |
| 2017 | 158 | 61 | 0% (0) | 66% | $45,878 |
| 2016 | 116 | 52 | None | 46% | $17,892 |
| 2015 | 82 | 33 | None | 54% | $11,377 |
| 2014 | 61 | 28 | None | 48% | $6,264 |
| 2013 | 64 | 24 | 31% (20) | 20% | $4,247 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Myrbetriq | 54 | $25,413 | $471 |
| Estring | 19 | $10,392 | $547 |
| Gemtesa | 18 | $8,865 | $493 |
| Estradiol | 55 | $7,626 | $139 |
| Methenamine Hippurate | 78 | $5,103 | $65 |
| Imvexxy | 15 | $5,063 | $338 |
| Fesoterodine Fumarate Er | 28 | $4,359 | $156 |
| Solifenacin | 28 | $823 | $29 |
| Nitrofurantoin Mono-Macro | 21 | $277 | $13 |
2022: 9 drugs
| Myrbetriq | 59 | $21,928 | $372 |
| Estring | 17 | $8,918 | $525 |
| Estradiol | 55 | $7,438 | $135 |
| Solifenacin | 73 | $7,079 | $97 |
| Methenamine Hippurate | 69 | $6,380 | $92 |
| Imvexxy | 17 | $6,058 | $356 |
| Trospium Chloride Er | 20 | $2,466 | $123 |
| Oxybutynin Chloride Er | 42 | $1,668 | $40 |
| Nitrofurantoin Mono-Macro | 16 | $215 | $13 |
2021: 8 drugs
| Myrbetriq | 87 | $32,083 | $369 |
| Imvexxy | 49 | $10,911 | $223 |
| Estring | 20 | $9,728 | $486 |
| Estradiol | 41 | $4,186 | $102 |
| Oxybutynin Chloride Er | 76 | $2,487 | $33 |
| Solifenacin | 37 | $2,113 | $57 |
| Tolterodine Tartrate Er | 14 | $444 | $32 |
| Nitrofurantoin Mono-Macro | 12 | $259 | $22 |
2020: 8 drugs
| Myrbetriq | 117 | $42,168 | $360 |
| Imvexxy | 23 | $5,330 | $232 |
| Tolterodine Tartrate Er | 13 | $2,354 | $181 |
| Oxybutynin Chloride Er | 59 | $1,758 | $30 |
| Estradiol | 12 | $1,407 | $117 |
| Nitrofurantoin Mono-Macro | 22 | $296 | $13 |
| Oxybutynin Chloride | 12 | $192 | $16 |
| Fluconazole | 14 | $88 | $6 |
2019: 6 drugs
| Myrbetriq | 118 | $39,030 | $331 |
| Estring | 12 | $5,609 | $467 |
| Estradiol | 17 | $3,289 | $193 |
| Imvexxy | 11 | $2,457 | $223 |
| Tolterodine Tartrate Er | 13 | $1,904 | $146 |
| Oxybutynin Chloride Er | 36 | $1,557 | $43 |
2018: 3 drugs
| Myrbetriq | 87 | $32,450 | $373 |
| Estring | 25 | $11,178 | $447 |
| Vesicare | 19 | $8,541 | $450 |
2017: 4 drugs
| Myrbetriq | 44 | $17,554 | $399 |
| Estring | 27 | $11,162 | $413 |
| Vesicare | 24 | $9,262 | $386 |
| Estrace | 12 | $3,559 | $297 |
2016: 4 drugs
| Vesicare | 20 | $8,460 | $423 |
| Myrbetriq | 18 | $3,725 | $207 |
| Nitrofurantoin Mono-Macro | 14 | $388 | $28 |
| Ciprofloxacin | 14 | $62 | $4 |
2015: 3 drugs
| Myrbetriq | 12 | $3,486 | $290 |
| Premarin | 13 | $3,364 | $259 |
| Ciprofloxacin | 12 | $46 | $4 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 14 | $84 | $6 |
| Ibuprofen | 19 | $80 | $4 |
Money from drug and device companies
$16 in 2024
| 2024 | 1 | 1 | None | $16 |
| 2023 | 1 | 1 | None | $13 |
| 2022 | 1 | 7 | None | $132 |
| 2021 | 1 | 1 | None | $61 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $16 | 1 payment
|
See the published payment
| Astellas Pharma US | Meals · 2024-02-23 | Veozah | $16 |
See earlier years (2023, 2022, 2021)
2023: $13
| Astellas Pharma US | Myrbetriq | $13 | 1 payment
|
2022: $132
| Astellas Pharma US | Myrbetriq | $132 | 7 payments
|
2021: $61
| Medtronic | Interstim | $61 | 1 payment
|
Professional record
- NPI
- 1285899138
- Licence
- AZ 296582, FL ARNP9278854, ND R33969, TX 1130981
- Group
- Bradley Gynecology PC · Omaha Therapy Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- ND 19953
- Taxonomy
- Federal specialty code 363LW0102X (363LW0102X); Federal specialty code 363LX0001X (363LX0001X)
- Mailing address
- 3100 N 11th St Ste 1, Bismarck, ND, 58503
- NPI first listed
- 2008-07-21
- NPI last updated
- 2025-03-13
- NPI record certified
- 2025-03-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3100 N 11th St Ste 1, Bismarck, ND, 58503 · 4254 W Orchid Ln, Chandler, AZ, 85226 · 20 Foundry St Fl 2, Concord, NH, 03301 · 1531 32nd Ave S Ste 102, Fargo, ND, 58103 · 112 Maverick Ct, Granbury, TX, 76049